Application of 5G Technology to Conduct Real-Time Teleretinal Laser Photocoagulation for the Treatment of Diabetic Retinopathy-Reference-Cited by-同舟云学术

Application of 5G Technology to Conduct Real-Time Teleretinal Laser Photocoagulation for the Treatment of Diabetic Retinopathy

Published:2021-09-01 Issue:9 Volume:139 Page:975
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Chen Huan¹,Pan Xuefeng²,Yang Jingyuan¹,Fan Jing³,Qin Mingwei³,Sun Hu⁴,Liu Jinxin⁵,Li Na⁵,Ting Daniel Shu Wei⁶,Chen Youxin¹

Affiliation:

1. Department of Ophthalmology, Peking Union Medical College Hospital, Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2. Department of Ophthalmology, Huzhou First People’s Hospital, Huzhou, China

3. Department of Telemedicine Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

4. Clin Medical Instrument Co, Ltd, Shanghai, China

5. China Mobile Communications Group Co, Ltd, Beijing, China

6. Singapore National Eye Center, Duke-NUS Medical School, Singapore

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2781796/jamaophthalmology_chen_2021_oi_210037_1631134777.08478.pdf

Reference19 articles.

1. Advances in telemedicine in ophthalmology.;Parikh;Semin Ophthalmol,2020

2. Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis.;Shi;Br J Ophthalmol,2015